Estradiol up-regulates antiapoptotic Bcl-2 messenger ribonucleic acid and protein in tumorigenic ovarian surface epithelium cells

Kyung Chul Choi, Sung Keun Kang, Chen Jei Tai, Nelly Auersperg, Peter C K Leung

Research output: Contribution to journalArticle

108 Citations (Scopus)

Abstract

Most epithelial ovarian tumors appear to arise from the ovarian surface epithelium (OSE). Even though it has been suggested that estrogen may be associated with ovarian tumorigenesis, the exact role of estrogen in the regulation of apoptosis in neoplastic OSE cells remains uncertain. Immortalized OSE (IOSE) cell lines were generated from human normal OSE. These cell lines represent early neoplastic (IOSE-29), tumorigenic (IOSE-29EC), and late neoplastic (IOSE-29EC/T4 and IOSE-29EC/T5) transformation stages from human normal OSE. The present studies demonstrated that both mRNAs and proteins of estrogen receptor (ER) α and β were expressed in IOSE cell lines. No difference was observed in normal OSE and IOSE-29 cells, whereas treatment with 17β-estradiol (E2; 10-8-10-6 M) resulted in an increased thymidine incorporation and DNA content per culture in IOSE-29EC cells. This effect of E2 was attenuated with tamoxifen treatment (10-6 M), the estrogen antagonist, suggesting that the effect of E2 is mediated through specific ERs. There was no stimulatory effect on thymidine incorporation before day 6, but after 6 days of E2 treatment, thymidine incorporation was significantly increased. Because the ratio of thymidine incorporation to DNA content per culture did not change, this E2 effect does not appear to indicate stimulation of proliferation but, rather, inhibition of apoptosis. In addition, treatment with tamoxifen (10-6 M) induced apoptosis up to 3-fold in IOSE-29EC cells, whereas cotreatment with E2 (10-8-10-6 M) plus tamoxifen attenuated tamoxifen-induced apoptosis in a dose-dependent manner. Both proapoptotic bax and antiapoptotic bcl-2 at messenger RNA (mRNA) and protein levels were expressed in IOSE cell lines. Interestingly, treatments with E2 resulted in a significant increase of bcl-2 mRNA and protein levels (2- and 1.7-fold, respectively), whereas no difference was observed in bax mRNA level. Thus, E2 may enhance survival of IOSE-29EC by up-regulating bcl-2, and antiapoptotic bcl-2 may be a dominant regulator of apoptotic pathway in these cells. In conclusion, the present study indicates that early neoplastic (IOSE-29), tumorigenic (IOSE-29EC), and late neoplastic (IOSE-29EC/T4 and T5) OSE cells expressed both ERα and ERβ at the mRNA and protein levels. In addition, E2 prevented tamoxifen induced-apoptosis through ERs. The mechanism of E2 action may be associated with up-regulation of bcl-2 gene at mRNA and protein levels. These results suggest that estrogen may play a role in ovarian tumorigenesis by preventing apoptosis in tumorigenic OSE cells.

Original languageEnglish
Pages (from-to)2351-2360
Number of pages10
JournalEndocrinology
Volume142
Issue number6
DOIs
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Estradiol
Up-Regulation
Epithelium
RNA
Tamoxifen
Apoptosis
Thymidine
Messenger RNA
Proteins
Cell Line
Estrogens
Estrogen Receptors
Carcinogenesis
Estrogen Antagonists
bcl-2 Genes
DNA
Survival
Neoplasms

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Estradiol up-regulates antiapoptotic Bcl-2 messenger ribonucleic acid and protein in tumorigenic ovarian surface epithelium cells. / Choi, Kyung Chul; Kang, Sung Keun; Tai, Chen Jei; Auersperg, Nelly; Leung, Peter C K.

In: Endocrinology, Vol. 142, No. 6, 2001, p. 2351-2360.

Research output: Contribution to journalArticle

Choi, Kyung Chul ; Kang, Sung Keun ; Tai, Chen Jei ; Auersperg, Nelly ; Leung, Peter C K. / Estradiol up-regulates antiapoptotic Bcl-2 messenger ribonucleic acid and protein in tumorigenic ovarian surface epithelium cells. In: Endocrinology. 2001 ; Vol. 142, No. 6. pp. 2351-2360.
@article{5be81358190f47ea9ed5ebdb8b68a1de,
title = "Estradiol up-regulates antiapoptotic Bcl-2 messenger ribonucleic acid and protein in tumorigenic ovarian surface epithelium cells",
abstract = "Most epithelial ovarian tumors appear to arise from the ovarian surface epithelium (OSE). Even though it has been suggested that estrogen may be associated with ovarian tumorigenesis, the exact role of estrogen in the regulation of apoptosis in neoplastic OSE cells remains uncertain. Immortalized OSE (IOSE) cell lines were generated from human normal OSE. These cell lines represent early neoplastic (IOSE-29), tumorigenic (IOSE-29EC), and late neoplastic (IOSE-29EC/T4 and IOSE-29EC/T5) transformation stages from human normal OSE. The present studies demonstrated that both mRNAs and proteins of estrogen receptor (ER) α and β were expressed in IOSE cell lines. No difference was observed in normal OSE and IOSE-29 cells, whereas treatment with 17β-estradiol (E2; 10-8-10-6 M) resulted in an increased thymidine incorporation and DNA content per culture in IOSE-29EC cells. This effect of E2 was attenuated with tamoxifen treatment (10-6 M), the estrogen antagonist, suggesting that the effect of E2 is mediated through specific ERs. There was no stimulatory effect on thymidine incorporation before day 6, but after 6 days of E2 treatment, thymidine incorporation was significantly increased. Because the ratio of thymidine incorporation to DNA content per culture did not change, this E2 effect does not appear to indicate stimulation of proliferation but, rather, inhibition of apoptosis. In addition, treatment with tamoxifen (10-6 M) induced apoptosis up to 3-fold in IOSE-29EC cells, whereas cotreatment with E2 (10-8-10-6 M) plus tamoxifen attenuated tamoxifen-induced apoptosis in a dose-dependent manner. Both proapoptotic bax and antiapoptotic bcl-2 at messenger RNA (mRNA) and protein levels were expressed in IOSE cell lines. Interestingly, treatments with E2 resulted in a significant increase of bcl-2 mRNA and protein levels (2- and 1.7-fold, respectively), whereas no difference was observed in bax mRNA level. Thus, E2 may enhance survival of IOSE-29EC by up-regulating bcl-2, and antiapoptotic bcl-2 may be a dominant regulator of apoptotic pathway in these cells. In conclusion, the present study indicates that early neoplastic (IOSE-29), tumorigenic (IOSE-29EC), and late neoplastic (IOSE-29EC/T4 and T5) OSE cells expressed both ERα and ERβ at the mRNA and protein levels. In addition, E2 prevented tamoxifen induced-apoptosis through ERs. The mechanism of E2 action may be associated with up-regulation of bcl-2 gene at mRNA and protein levels. These results suggest that estrogen may play a role in ovarian tumorigenesis by preventing apoptosis in tumorigenic OSE cells.",
author = "Choi, {Kyung Chul} and Kang, {Sung Keun} and Tai, {Chen Jei} and Nelly Auersperg and Leung, {Peter C K}",
year = "2001",
doi = "10.1210/en.142.6.2351",
language = "English",
volume = "142",
pages = "2351--2360",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "6",

}

TY - JOUR

T1 - Estradiol up-regulates antiapoptotic Bcl-2 messenger ribonucleic acid and protein in tumorigenic ovarian surface epithelium cells

AU - Choi, Kyung Chul

AU - Kang, Sung Keun

AU - Tai, Chen Jei

AU - Auersperg, Nelly

AU - Leung, Peter C K

PY - 2001

Y1 - 2001

N2 - Most epithelial ovarian tumors appear to arise from the ovarian surface epithelium (OSE). Even though it has been suggested that estrogen may be associated with ovarian tumorigenesis, the exact role of estrogen in the regulation of apoptosis in neoplastic OSE cells remains uncertain. Immortalized OSE (IOSE) cell lines were generated from human normal OSE. These cell lines represent early neoplastic (IOSE-29), tumorigenic (IOSE-29EC), and late neoplastic (IOSE-29EC/T4 and IOSE-29EC/T5) transformation stages from human normal OSE. The present studies demonstrated that both mRNAs and proteins of estrogen receptor (ER) α and β were expressed in IOSE cell lines. No difference was observed in normal OSE and IOSE-29 cells, whereas treatment with 17β-estradiol (E2; 10-8-10-6 M) resulted in an increased thymidine incorporation and DNA content per culture in IOSE-29EC cells. This effect of E2 was attenuated with tamoxifen treatment (10-6 M), the estrogen antagonist, suggesting that the effect of E2 is mediated through specific ERs. There was no stimulatory effect on thymidine incorporation before day 6, but after 6 days of E2 treatment, thymidine incorporation was significantly increased. Because the ratio of thymidine incorporation to DNA content per culture did not change, this E2 effect does not appear to indicate stimulation of proliferation but, rather, inhibition of apoptosis. In addition, treatment with tamoxifen (10-6 M) induced apoptosis up to 3-fold in IOSE-29EC cells, whereas cotreatment with E2 (10-8-10-6 M) plus tamoxifen attenuated tamoxifen-induced apoptosis in a dose-dependent manner. Both proapoptotic bax and antiapoptotic bcl-2 at messenger RNA (mRNA) and protein levels were expressed in IOSE cell lines. Interestingly, treatments with E2 resulted in a significant increase of bcl-2 mRNA and protein levels (2- and 1.7-fold, respectively), whereas no difference was observed in bax mRNA level. Thus, E2 may enhance survival of IOSE-29EC by up-regulating bcl-2, and antiapoptotic bcl-2 may be a dominant regulator of apoptotic pathway in these cells. In conclusion, the present study indicates that early neoplastic (IOSE-29), tumorigenic (IOSE-29EC), and late neoplastic (IOSE-29EC/T4 and T5) OSE cells expressed both ERα and ERβ at the mRNA and protein levels. In addition, E2 prevented tamoxifen induced-apoptosis through ERs. The mechanism of E2 action may be associated with up-regulation of bcl-2 gene at mRNA and protein levels. These results suggest that estrogen may play a role in ovarian tumorigenesis by preventing apoptosis in tumorigenic OSE cells.

AB - Most epithelial ovarian tumors appear to arise from the ovarian surface epithelium (OSE). Even though it has been suggested that estrogen may be associated with ovarian tumorigenesis, the exact role of estrogen in the regulation of apoptosis in neoplastic OSE cells remains uncertain. Immortalized OSE (IOSE) cell lines were generated from human normal OSE. These cell lines represent early neoplastic (IOSE-29), tumorigenic (IOSE-29EC), and late neoplastic (IOSE-29EC/T4 and IOSE-29EC/T5) transformation stages from human normal OSE. The present studies demonstrated that both mRNAs and proteins of estrogen receptor (ER) α and β were expressed in IOSE cell lines. No difference was observed in normal OSE and IOSE-29 cells, whereas treatment with 17β-estradiol (E2; 10-8-10-6 M) resulted in an increased thymidine incorporation and DNA content per culture in IOSE-29EC cells. This effect of E2 was attenuated with tamoxifen treatment (10-6 M), the estrogen antagonist, suggesting that the effect of E2 is mediated through specific ERs. There was no stimulatory effect on thymidine incorporation before day 6, but after 6 days of E2 treatment, thymidine incorporation was significantly increased. Because the ratio of thymidine incorporation to DNA content per culture did not change, this E2 effect does not appear to indicate stimulation of proliferation but, rather, inhibition of apoptosis. In addition, treatment with tamoxifen (10-6 M) induced apoptosis up to 3-fold in IOSE-29EC cells, whereas cotreatment with E2 (10-8-10-6 M) plus tamoxifen attenuated tamoxifen-induced apoptosis in a dose-dependent manner. Both proapoptotic bax and antiapoptotic bcl-2 at messenger RNA (mRNA) and protein levels were expressed in IOSE cell lines. Interestingly, treatments with E2 resulted in a significant increase of bcl-2 mRNA and protein levels (2- and 1.7-fold, respectively), whereas no difference was observed in bax mRNA level. Thus, E2 may enhance survival of IOSE-29EC by up-regulating bcl-2, and antiapoptotic bcl-2 may be a dominant regulator of apoptotic pathway in these cells. In conclusion, the present study indicates that early neoplastic (IOSE-29), tumorigenic (IOSE-29EC), and late neoplastic (IOSE-29EC/T4 and T5) OSE cells expressed both ERα and ERβ at the mRNA and protein levels. In addition, E2 prevented tamoxifen induced-apoptosis through ERs. The mechanism of E2 action may be associated with up-regulation of bcl-2 gene at mRNA and protein levels. These results suggest that estrogen may play a role in ovarian tumorigenesis by preventing apoptosis in tumorigenic OSE cells.

UR - http://www.scopus.com/inward/record.url?scp=0035009393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035009393&partnerID=8YFLogxK

U2 - 10.1210/en.142.6.2351

DO - 10.1210/en.142.6.2351

M3 - Article

C2 - 11356682

AN - SCOPUS:0035009393

VL - 142

SP - 2351

EP - 2360

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 6

ER -